BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 54.12
0.00 (0.00%)
At close: Oct 31, 2025
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €10.36 billion as of November 3, 2025. Its market cap has increased by 127.78% in one year.
Market Cap
10.36B
Enterprise Value
11.42B
Revenue
301.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€54.12
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 10.36B, an increase of 254.67%. That is a compound annual growth rate of 22.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 10.36B | 106.81% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | 7.13B | 84.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 99.74B |
| Intesa Sanpaolo | 96.13B |
| Enel SpA | 89.08B |
| Ferrari | 61.55B |
| Assicurazioni Generali | 50.64B |
| Eni S.p.A. | 48.36B |
| Leonardo S.p.a. | 29.33B |
| Poste Italiane | 27.03B |